FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.3  |  FHIR Version n/a  User: [n/a]

872471000168100: Plasma-Lyte 148 Replacement (magnesium chloride hexahydrate 300 mg / 1 L + potassium chloride 370 mg / 1 L + sodium acetate trihydrate 3.68 g / 1 L + sodium chloride 5.26 g / 1 L + sodium gluconate 5.02 g / 1 L) injection, 1 L bag (trade product unit of use)

Status: current, Defined. Date: 31-Jan 2017. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
3134821000168114 Plasma-Lyte 148 Replacement (magnesium chloride hexahydrate 300 mg / 1 L + potassium chloride 370 mg / 1 L + sodium acetate trihydrate 3.68 g / 1 L + sodium chloride 5.26 g / 1 L + sodium gluconate 5.02 g / 1 L) injection, 1 L bag (trade product unit of use) en Fully specified name Active Case sensitive Australian Medicines Terminology module
3134831000168112 Plasma-Lyte 148 Replacement injection, 1 L bag en Synonym Active Case sensitive Australian Medicines Terminology module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Plasma-Lyte 148 Replacement injection, 1 L bag has manufactured dose form injection true Inferred relationship Some
Plasma-Lyte 148 Replacement injection, 1 L bag Is a Plasma-Lyte 148 Replacement true Inferred relationship Some
Plasma-Lyte 148 Replacement injection, 1 L bag Is a trade product unit of use true Inferred relationship Some
Plasma-Lyte 148 Replacement injection, 1 L bag Is a sodium chloride 5.26 g/L + sodium gluconate 5.02 g/L + sodium acetate trihydrate 3.68 g/L + potassium chloride 370 mg (potassium 5 mmol)/L + magnesium chloride hexahydrate 300 mg/L injection, bag true Inferred relationship Some
Plasma-Lyte 148 Replacement injection, 1 L bag has manufactured dose form intravenous infusion injection false Inferred relationship Some
Plasma-Lyte 148 Replacement injection, 1 L bag has unit of use bag true Inferred relationship Some 1894022607
Plasma-Lyte 148 Replacement injection, 1 L bag has Australian BoSS magnesium chloride hexahydrate true Inferred relationship Some 317634051
Plasma-Lyte 148 Replacement injection, 1 L bag has intended active ingredient magnesium chloride true Inferred relationship Some 317634051
Plasma-Lyte 148 Replacement injection, 1 L bag has intended active ingredient sodium chloride true Inferred relationship Some 1258615762
Plasma-Lyte 148 Replacement injection, 1 L bag has Australian BoSS sodium chloride true Inferred relationship Some 1258615762
Plasma-Lyte 148 Replacement injection, 1 L bag has Australian BoSS sodium acetate trihydrate true Inferred relationship Some 1036275266
Plasma-Lyte 148 Replacement injection, 1 L bag has intended active ingredient sodium acetate trihydrate true Inferred relationship Some 1036275266
Plasma-Lyte 148 Replacement injection, 1 L bag has Australian BoSS sodium gluconate true Inferred relationship Some 600606002
Plasma-Lyte 148 Replacement injection, 1 L bag has intended active ingredient sodium gluconate true Inferred relationship Some 600606002
Plasma-Lyte 148 Replacement injection, 1 L bag has intended active ingredient potassium chloride true Inferred relationship Some 1894022606
Plasma-Lyte 148 Replacement injection, 1 L bag has Australian BoSS potassium chloride true Inferred relationship Some 1894022606
Inbound Relationships Type Active Source Characteristic Refinability Group
Plasma-Lyte 148 Replacement injection, 1 L bag has TPUU True Plasma-Lyte 148 Replacement injection, 1 L bag Inferred relationship Some 1
Plasma-Lyte 148 Replacement injection, 1 L bag has TPUU True Plasma-Lyte 148 Replacement injection, 1 L bag Inferred relationship Some 1

Reference Sets

Trade product unit of use reference set

Back to Start